Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations

被引:52
作者
Attur, Mukundan
Wang, Hwa-Ying [2 ]
Kraus, Virginia Byers [3 ]
Bukowski, Jack F. [2 ,4 ]
Aziz, Nazneen [2 ]
Krasnokutsky, Svetlana
Samuels, Jonathan
Greenberg, Jeffrey
McDaniel, Gary [3 ]
Abramson, Steven B. [1 ]
Kornman, Kenneth S. [2 ]
机构
[1] NYU, Hosp Joint Dis, Div Rheumatol, New York, NY 10003 USA
[2] Interleukin Genet, Waltham, MA USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Harvard Univ, Sch Med, Boston, MA USA
关键词
CANDIDATE GENES; ASSOCIATION; POLYMORPHISMS; EXPRESSION; ARTHRITIS; IL-10; INFLAMMATION; SUPPRESSION; PROGRESSION; HAPLOTYPE;
D O I
10.1136/ard.2009.113043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A lack of biomarkers that identify patients at risk for severe osteoarthritis (OA) complicates development of disease-modifying OA drugs. Objective To determine whether inflammatory genetic markers could stratify patients with knee OA into high and low risk for destructive disease. Methods Genotype associations with knee OA severity were assessed in two Caucasian populations. Fifteen single nucleotide polymorphisms (SNPs) in six infl ammatory genes were evaluated for association with radiographic severity and with synovial fluid mediators in a subset of the patients. Results Interleukin 1 receptor antagonist (IL1RN) SNPs (rs419598, rs315952 and rs9005) predicted Kellgren-Lawrence scores independently in each population. One IL1RN haplotype was associated with lower odds of radiographic severity (OR=0.15; 95% CI 0.065 to 0.349; p<0.0001), greater joint space width and lower synovial fluid cytokine levels. Carriage of the IL1RN haplotype influenced the age relationship with severity. Conclusion IL1RN polymorphisms reproducibly contribute to disease severity in knee OA and may be useful biomarkers for patient selection in diseasemodifying OA drug trials.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 29 条
[1]   Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type IIIL-1 decoy receptor - Potential for pharmacological intervention [J].
Attur, MG ;
Dave, M ;
Cipolletta, C ;
Kang, P ;
Goldring, MB ;
Patel, IR ;
Abramson, SB ;
Amin, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40307-40315
[2]   Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis - Suppression of collagenase-1 expression [J].
Caron, JP ;
Fernandes, JC ;
MartellPelletier, J ;
Tardif, G ;
Mineau, F ;
Geng, CS ;
Pelletier, JP .
ARTHRITIS AND RHEUMATISM, 1996, 39 (09) :1535-1544
[3]   Lipopolysaccharide primes neutrophils for a rapid response to IL-10 [J].
Cassatella, MA ;
Tamassia, N ;
Crepaldi, L ;
McDonald, PP ;
Ear, T ;
Calzetti, F ;
Gasperini, S ;
Zanderigo, F ;
Bazzoni, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (06) :1877-1885
[4]  
Chevalier X, 2005, J RHEUMATOL, V32, P1317
[5]   Polymorphisms in the Interleukin-1 Receptor Antagonist and Interleukin-6 Genes Affect Risk of Osteolysis in Patients With Total Hip Arthroplasty [J].
Gordon, Andrew ;
Kiss-Toth, E. ;
Stockley, Ian ;
Eastell, Richard ;
Wilkinson, J. Mark .
ARTHRITIS AND RHEUMATISM, 2008, 58 (10) :3157-3165
[6]  
Kahraman S, 2006, J NEPHROL, V19, P50
[7]   Interleukin-1β gene polymorphism associated with radiographic signs of osteoarthritis of the knee [J].
Kanoh, Toshiya ;
Hasegawa, Yukiharu ;
Masui, Tetsuo ;
Yamaguchi, Jin ;
Ishiguro, Naoki ;
Hamajima, Nobuyuki .
JOURNAL OF ORTHOPAEDIC SCIENCE, 2008, 13 (02) :97-100
[8]   Urea as a passive transport marker for arthritis biomarker studies [J].
Kraus, VB ;
Huebner, JL ;
Fink, C ;
King, JB ;
Brown, S ;
Vail, TP ;
Guilak, F .
ARTHRITIS AND RHEUMATISM, 2002, 46 (02) :420-427
[9]   Association of the interleukin-1 gene cluster on chromosome 2q13 with knee osteoarthritis [J].
Loughlin, J ;
Dowling, B ;
Mustafa, Z ;
Chapman, K .
ARTHRITIS AND RHEUMATISM, 2002, 46 (06) :1519-1527
[10]  
Moos V, 2000, ARTHRITIS RHEUM, V43, P2417, DOI 10.1002/1529-0131(200011)43:11<2417::AID-ANR7>3.0.CO